Sanofi, Regeneron Expand Alliance in Deal Up to $8 Billion
Drugmakers Sanofi and Regeneron Pharmaceuticals have agreed to expand their alliance as part of a deal valued at up to $8 billion. The companies have also settled prior collaboration-related litigation.